The purpose of this study is to confirm the safety and effectiveness of the ActiSight™ Needle Guidance System with CT-guided percutaneous (through the skin) liver biopsies and ablations . The device used in this study is designed to assist the physician in guiding the needle towards the suspected area. This device does not change the procedure of liver biopsy or ablation. The only difference is that a small adhesive pad is placed on the skin and a miniature video camera is attached to the end of the needle. This camera does not enter the body.
Study Type
INTERVENTIONAL
Allocation
NA
Masking
NONE
Enrollment
20
biopsy or ablation performed as in standard of care with assistance of ActiSight Needle Guidance system
Royal Victoria Hospital
Montreal, Quebec, Canada
accuracy
Frequency of placing the needle at a location suitable for the planned intervention, as determined by the investigator reviewing the CT images.
Time frame: during the procedure
time
Total CT-Guided procedure time, starting with scan for entry point planning;
Time frame: during the procedure
time
Time required to guide the needle to the target
Time frame: during the procedure
radiation
Subject radiation exposure during the procedure
Time frame: during the procedure
total number of scans
Number of CT scans during the procedure
Time frame: during the procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.